Posaconazole recalls
The FDA has published 2 recalls involving Posaconazole since 2023. The latest was reported on 31 Dec 2025. Most were for potency & assay. Merck Sharp & Dohme has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2023
Last 12 months1reported
Class I00% of total
Ongoing1latest 31 Dec 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why posaconazole is recalled
Companies
Brands
By year
Ongoing posaconazole recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Noxafil Powdermix (posaconazole) recalled by Merck Sharp & DohmeNoxafil | Merck Sharp & Dohme | Particulate Matter | Nationwide |
All posaconazole recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Noxafil Powdermix (posaconazole) recalled by Merck Sharp & DohmeNoxafil | Merck Sharp & Dohme | Particulate Matter | Nationwide |
| Drug | CLASS II | Posaconazole Delayed-Release Tablets, 100 mg recalled by Biocon PharmaPosaconazole | Biocon Pharma | Potency & Assay | Nationwide |
Should you stop taking Posaconazole?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.